In tumors of the skin, maspin immunoreactivity was described in 97 % of squamous cell carcinomas and 88 % of basal cell carcinomas, but also in malignant melanomas, more frequent in sun-exposed areas [32, 33]. This evidence concerns the gene SERPINB5 and basal cell carcinoma.